Merck's $5B Lipfendra FDA Approval Revolutionizes Cholesterol | Pharma and Biotech Daily

Merck's $5B Lipfendra FDA Approval Revolutionizes Cholesterol | Pharma and Biotech Daily

Author: Pharma and BioTech News July 17, 2026 Duration: 4:46
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The industry continues to forge ahead, making significant strides in scientific advancements, regulatory approvals, and strategic business developments. These moves are reshaping the landscape of drug development and patient care. Starting with Merck & Co.'s recent FDA approval for Lipfendra, the world’s first oral PCSK9 inhibitor, this marks a pivotal shif...

Every morning, the world of life sciences shifts with new clinical data, strategic deals, and regulatory decisions. Keeping pace with it all is a full-time job. Pharma and BioTech Daily is designed to be that essential, efficient briefing for professionals and investors who need the signal through the noise. This daily podcast delivers a concise, human-curated audio update that synthesizes the most critical developments from the previous day. You’ll hear clear summaries of pipeline milestones, merger and acquisition activity, policy changes, and corporate strategy shifts-all contextualized for their real-world impact. The production leverages AI tools to monitor vast data streams, but each episode is carefully supervised and narrated by editors to ensure accuracy and relevance. It’s for anyone who builds companies in this space, manages portfolios, or makes strategic decisions where science meets business. Tune in for a focused, factual, and time-saving digest that fits into your morning routine, brought to you by the team at Pharma and BioTech News and produced by the boutique studio OWITH.ai. This isn't about lengthy interviews or opinion; it's a streamlined tool to inform your day in the complex, fast-moving pharma and biotech landscape.
Author: Language: en-us Episodes: 50

Pharma and BioTech Daily
Podcast Episodes
Scholar Rock's $20B Pharma Shakeup & More | Pharma and Biotech Daily [not-audio_url] [/not-audio_url]

Duration: 5:10
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today’s episode delves into some of the latest breakthroughs, regulatory updates, and s…
FDA Expands Bayer's Hyrnuo Approval | Pharma and Biotech Daily [not-audio_url] [/not-audio_url]

Duration: 4:55
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the significant advancements and challenges that are shaping the f…